Form4insider filings, from the source

SEC Form 5 · accession 0001611650-16-000005

Immune Therapeutics, Inc. · IMUN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Noreen Griffin
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Dec 31, 2015
Accepted (ET)
Mar 30, 2016 · 8:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
COMMON STOCKF2,F1Sep 1, 2015J1,000,000$0.00A4,317,710D
COMMON STOCKF3Sep 1, 2015J2,000,000$0.00A4,317,710IGRIFFIN FAMILY IRREVOCABLE TRUST
COMMON STOCKF4,F1,F3Sep 17, 2015J1,300,000$0.00A4,317,710IGRIFFIN FAMILY IRREVOCABLE TRUST
COMMON STOCKDec 4, 2015J1,000,000$50,000.00D4,317,710D
COMMON STOCKF2,F3Dec 31, 2015J2,000,000$0.00D4,317,710IGRIFFIN FAMILY IRREVOCABLE TRUST
COMMON STOCKF4,F1,F3Dec 31, 2015J1,300,000$0.00D4,317,710IGRIFFIN FAMILY IRREVOCABLE TRUST

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses